Medicine and Health

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

P. Mlcochova, S. A. Kemp, et al.

The B.1.617.2 (Delta) variant of SARS-CoV-2 poses a significant challenge as it exhibits reduced sensitivity to neutralizing antibodies and increased replication efficiency. Conducted by a diverse team of authors, including Petra Mlcochova and Steven A. Kemp, this research highlights the urgent need for continued infection control measures to combat the Delta variant's immune evasion strategies.

00:00

Playback language: English

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways

M. Gagne, B. J. Flynn, et al.

Biology

SARS-CoV-2 variant biology: immune escape, transmission and fitness

A. M. Carabelli, T. P. Peacock, et al.

Biology

Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia

J. Y. L. Fu, M. H. Pukhari, et al.

Medicine and Health

Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants

C. Sun, Y. Kang, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny